A recent study reported that fibroblasts of a patient with Alzheimer’s disease (AD) had approximately 25% ALDH2 activity relative to the fibroblasts of a healthy subject. This evidence concerns the gene ALDH2 and early-onset autosomal dominant Alzheimer disease.